EMILY WOODALL: Open Payments
NPI 1417971136 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 62 payments from 13 companies in 2025. Trend: 2023 $397 · 2024 $588 · 2025 $1,496
Food & beverage: $1,311Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $467 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $225 |
| UCB, Inc. | 8 | $223 |
| ABBVIE INC. | 8 | $201 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| Amgen Inc. | 4 | $63 |
| Lilly USA, LLC | 3 | $57 |
| Organon LLC | 2 | $36 |
| GENZYME CORPORATION | 1 | $29 |
| LEO Pharma Inc. | 1 | $24 |
Products named: TREMFYA, Bimzelx, SKYRIZI, COSENTYX, ILUMYA, Otezla, TALTZ, RINVOQ.
Industry payments across VA — which companies pay providers there.
